2023-07-31媒体报道|中国siRNA公司,如何参与功能性治愈乙肝竞争?
近日,动脉新医药访谈了星曜坤泽执行总裁马彦琴女士,文章来源于动脉新医药,作者张钰。 小核酸药物近两年的表现可以用“锋芒毕露”来形容。2022年,小核酸药物公司Sarepta全年的净产...
Read more 2023-05-24Hepa Thera Announces First CHB Patient Dosed in HT-101 (Its siRNA Product) Phase 1b Part
ThisweekSuzhouHepaTheraBiotechCo.,LtdenrolledthefirstchronichepatitisBpatientinBeijingFriendshipHosp...
Read more 2022-11-24First subject administration with the first domestic GalNAc-siRNA product for hepatitis B treatment
OnNovember23,2022,thefirstdomesticGalNAc-siRNAproduct-HT-101InjectionforhepatitisBtreatmentdevelope...
Read more 2022-10-09Hepa Thera, an innovative drug R&D platform focusing on liver diseases, is hatched and established, and finishes the seed round financing
Recently,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaTheraBio.),aninnovativedrugR&Dplatformfocu...
Read more 2022-10-09Hepa Thera finishes angel round financing, focusing on building a new liver disease treatment platform
Recently,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera)completedtheangelroundfinancingofRMB30m...
Read more 2022-10-09A hope for patients with chronic hepatitis B - Hepa Thera submits pre-IND application for domestic hepatitis B siRNA drug!
Recently,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera),aninnovativeplatformcompanyforliverdise...
Read more 2022-10-09A hope for patients with chronic hepatitis B - Hepa Thera’s IND application for domestic hepatitis B siRNA drug is accepted!
SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera)isaninnovativeplatformcompanyforliverdiseasetrea...
Read more 2022-10-09A hope for patients with chronic hepatitis B - Hepa Thera submits pre-IND application for domestic hepatitis B surface antigen neutralizing antibody (HT-102)
Thisweek,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera),aninnovativeplatformcompanyforliverdis...
Read more